Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is an expanded access designed to provide access to apixaban for eligible participants.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Apixaban | Drug | Administered as directed by treating physician |
|
Inclusion Criteria:
Exclusion Criteria:
Other inclusion/exclusion criteria apply
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, | Contact | please email: | Clinical.Trials@bms.com | |
| First line of the email MUST contain NCT # and Site #. | Contact |
| Name | Affiliation | Role |
|---|---|---|
| Bristol-Myers Squibb | Bristol-Myers Squibb | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Childrens Hospital Of Philadelphia | Available | Philadelphia | Pennsylvania | 19104 | United States |
Not provided
| Label | URL |
|---|---|
| Pre-Approval Access (PAA) Healthcare Practitioner Requests | View source |
| BMS Clinical Trial Information | View source |
| FDA Safety Alerts and Recalls |
Not provided
Not provided
| ID | Term |
|---|---|
| C522181 | apixaban |
Not provided
Not provided
Not provided
| View source |
| BMS Clinical Trial Patient Recruiting | View source |